133993-34-7Relevant articles and documents
NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS
-
Paragraph 0298, (2019/01/21)
The present invention discloses compounds according to Formula (I) Wherein R1, R2, L, A1, A2, A3, Cy and the subscript n are as defined herein. The present invention relates to antagonists compounds of sphingosine 1-phosphate (SIP) receptor, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, inflammatory diseases, respiratory diseases, autoimmune diseases, metabolic diseases, cardiovascular diseases, and/or proliferative diseases by administering the compound of the invention.
Synthesis of New Benzofuro and Indolobenzoazepin-6-ones
Viti, Giovanni,Giannotti, Danilo,Nannicini, Rossano,Ricci, Renzo,Pestellini, Vittorio
, p. 379 - 384 (2007/10/02)
Three new tetracyclic structures, containing the azepine ring, were synthesized: 11,12-dihydro-6H-benzofurobenzoazepine-6,11-dione, 5,6,11,12-tetrahydroindolobenzoazepine-6,11-dione and 11,12-dihydro-6H-benzofurobenzoazepin-6